MedPAC recommendation of 0% pay increase for 2012 leaves long-term care providers fuming

Long-term care groups on Tuesday strongly criticized the latest round of recommendations to Congress from the Medicare Payment Advisory Commission.

Among its recommendations issued Tuesday for 2012, MedPAC suggested that skilled nursing facilities and long-term care hospitals receive no payment increases—not even cost-of-living adjustments.

The American Health Care Association and the Alliance for Quality Nursing Home Care excoriated the advisory commission's stance. By not providing even a cost-of-living adjustment, MedPAC and Congress could be jeopardizing caregivers' ability to continue to improve patient care quality, according to the long-term care groups.

“Stable Medicare funding is critical to extending this positive trend in improving quality, especially at a time when volatility in state Medicaid budgets has created a dramatic and worrisome squeeze on patient care, staffing and facilities themselves,” according to AHCA president and CEO Mark Parkinson and Alliance President Alan G. Rosenbloom.

MedPAC routinely recommends that reimbursements for nursing homes and long-term care facilities be cut or remain static. Congress has yet to follow their advice in recent memory. (McKnight's, 12/14/09)

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.